Vortex Energy Enters Into Asset Purchase Agreement to Acquire the Meadows Project in Saskatchewan
VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce that it has entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Global Strategic Minerals Corp. (the “Vendor”), pursuant to which the Company will acquire (the “Transaction”) the Purchased Assets (as defined below) comprising the Meadows Project (the “Project”) located in west-central Saskatchewan near the Alberta border (the “Meadows Project”).
Covered in this story
What has happened since
- Vertex Pharmaceuticals is down 1.8% since this was published, 32 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Vertex Pharmaceuticals
- UBS: $528 → $615 by Sep 2027 · Buy via Investing.com
- H.C. Wainwright: $515 → $641 by Sep 2027 · Buy via Investing.com
- BMO Capital Markets: $515 → $600 by Sep 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VRTX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vertex Pharmaceuticals →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.